Literature DB >> 19262982

Occipital ganglio-neuroblastoma in an adult.

Giovanni Sabatino1, Libero Lauriola, Stefano Sioletic, Alfredo Puca.   

Abstract

INTRODUCTION: Ganglioneuroblastomas (GNBs) are embryonic neoplasms, whose behaviour are not well established; 80% of cases occur in the first decade, while only two cases in the adulthood had been reported. CLINICAL REPORT: This 60-year-old female presented with a 2-month history of headache, vertigo, amnesia. A right brachio-crural hemiparesis, right homonymous hemianopsia and sensorial dysphasia was evident. A CT scan revealed a left occipital lesion. MRI scan was not performed because the patient had an anal sphincter stimulator. Three years before thyroidectomy for a follicular carcinoma was performed. A total body CT scan was negative. A left occipital craniotomy was carried out and a solid mass was totally excised. A diagnosis of GNB was made from histopathological examination and immunohistochemistry. Post-operatively the patient recovered from the hemiparesis while the visual disturbances persisted. She underwent fractioned radiotherapy (60 Gy) and chemotherapy with Temozolomide. She remained disease free 18 months after diagnosis. A CT scan showed no evidence of recurrence. DISCUSSION: Recent observations suggest that in spite of an embryonal appearance, these tumours are circumscribed and have a better prognosis than malignant gliomas.

Entities:  

Mesh:

Year:  2009        PMID: 19262982     DOI: 10.1007/s00701-009-0227-3

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  2 in total

1.  Ventricular ganglioneuroblastoma in an adult and successful treatment with radiotherapy.

Authors:  Mustafa Akın; Sefika Arzu Ergen; Büge Oz; Gülyüz Atkovar; Ismet Sahinler
Journal:  Balkan Med J       Date:  2014-06-01       Impact factor: 2.021

2.  Promoter hypermethylation as a mechanism for Lamin A/C silencing in a subset of neuroblastoma cells.

Authors:  Ines Rauschert; Fabian Aldunate; Jens Preussner; Miguel Arocena-Sutz; Vanina Peraza; Mario Looso; Juan C Benech; Ruben Agrelo
Journal:  PLoS One       Date:  2017-04-19       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.